Cancer Dependency Map Analytics
Cancer, Ageing and Somatic Mutation
In partnership with Open Targets, we provide computational support and analytic solutions to the international Cancer Dependency Map consortium, and to other projects engaged in the analysis of data from large-scale chemo/genetic screens.
Core team
Dr Clare Pacini
Principal Bioinformatician
Previous core team members
Dr Ichcha Manipur
Visiting Scientist
Valeria Mirici Cappa
Visiting Scientist
Alessandro Vinceti
Visiting Scientist
Associated research
Related groups
Partners
We work with the following groups
External
Open Targets
Open Targets is a pioneering public-private partnership between Biogen, Celgene, EMBL-EBI, GlaxoSmithKline (GSK), Takeda, and the Wellcome Sanger Institute and is located on the Wellcome Genome Campus. Open Targets brings together expertise from six complementary institutions to systematically identify and prioritise targets from which safe and effective medicines can be developed, to help others find good targets, and to get those targets adopted into drug discovery pipelines.Current focuses are oncology, immunology and neurodegeneration through an R&D framework that can be applied to all aspects of human disease.